CIA
REGN icon

Choate Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Choate Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-316
Closed -$244K – 483
2026
Q1 		$244K Hold
316
– – ﹤0.01% 402
2025
Q4 		$244K Buy
+316
New +$215K ﹤0.01% 402
2025
Q2 		– Sell
-561
Closed -$356K – 485
2025
Q1 		$356K Buy
561
+10
+2% +$6.88K 0.01% 304
2024
Q4 		$392K Buy
551
+37
+7% +$31.1K 0.01% 295
2024
Q3 		$540K Buy
514
+21
+4% +$23.4K 0.01% 259
2024
Q2 		$518K Sell
493
-2
-0.4% -$1.94K 0.01% 246
2024
Q1 		$476K Sell
495
-60
-11% -$57.1K 0.01% 272
2023
Q4 		$487K Sell
555
-76
-12% -$62.6K 0.02% 247
2023
Q3 		$519K Buy
631
+109
+21% +$85.7K 0.02% 235
2023
Q2 		$375K Buy
522
+128
+32% +$98.7K 0.02% 224
2023
Q1 		$324K Hold
394
– – 0.02% 221
2022
Q4 		$284K Hold
394
– – 0.02% 227
2022
Q3 		$271K Hold
394
– – 0.02% 210
2022
Q2 		$233K Hold
394
– – 0.01% 237
2022
Q1 		$275K Hold
394
– – 0.01% 255
2021
Q4 		$249K Hold
394
– – 0.01% 254
2021
Q3 		$238K Hold
394
– – 0.02% 243
2021
Q2 		$220K Buy
+394
New +$200K 0.01% 253
2013
Q4 		– Sell
-729
Closed -$228K – 267
2013
Q3 		$228K Buy
+729
New +$192K 0.02% 238

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Choate Investment Advisors's REGN Position: Q2 2026 in Review

Choate Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 316 shares — an estimated $244K sold.

Choate Investment Advisors first reported a position in REGN in Q3 2013 and held it in 19 quarters. The position peaked at $540K in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Choate Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Choate Investment Advisors sold 316 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $244K.
  • Choate Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 19 quarters.
  • Choate Investment Advisors's Regeneron Pharmaceuticals position peaked at $540K in Q3 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.